Syringes are medical devices used to inject fluid or withdraw fluid from the body. A medical syringe consists of a needle attached to a hollow cylinder that is fitted with a sliding plunger. They are mainly made from plastic and disposables and are majorly used in the healthcare practices. High-end syringes such as microliter syringes are made from glass material. Increasing utilization of medical test for diagnosis of diseases that requires intravenous modes of injection using syringes is major factor driving growth of the syringes market. According to National Health Council, around 75% of the total healthcare costs are a result of chronic diseases reflecting an increasing demand for proper healthcare requirements in terms of quality, safety, and sterility of medical devices. According to the same source, in 2014, around 133 million people were affected with chronic diseases in the U.S.

Get In-Depth Sample Copy of Syringes Market Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/917

North America is expected to dominate the global syringes market, owing to government initiatives and well established healthcare infrastructure

On the basis of geography, the global syringes market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is holding the dominant position in market, followed by Europe, owing to availability of advanced medical facilities and healthcare centers in the U.S. Increasing government initiatives to improve quality of healthcare in the region is also fueling growth of the market in North America. For instance, the Needle stick Safety and Prevention Act in the U.S., provides regulatory guidelines to help manufacturers improve safety of syringes. Syringes market in Asia Pacific region is expected to grow at significant rate over the forecast period, owing to technological implementation for producing better and cheaper syringes and increasing awareness regarding safe use of syringes in medical procedures.

Increasing prevalence of chronic diseases is expected to be the major factor driving growth of the global syringes market

Increasing prevalence of chronic diseases such as diabetes and cancer, which require continuous diagnosis using various medical test which requires use of syringes is major factor boosting growth of the market. For instance, according to World Health Organization (WHO) in 2014, around 422 million people were suffering from diabetes worldwide. Many of these patients were advised regular intravenous administration of insulin, which propelled the demand for use syringes in turn fueling growth of the global syringes market. Furthermore, increasing health hazards and infectious diseases are creating conducive environment for growth of syringes market. However, advancement in technologies such as diffusion pumps and needle- free IV connectors, which reduces the need of injecting fluid through syringe are expected to restrain growth of the market over the forecast period.

Global Major Players

Major players operating in the global syringes market include Treumo Corporation, Medtronic Plc, Becton, Dickinson and Company, B. Braun Medical Inc., Smiths Medical, Hindustan Syringes and Medical Devices Limited, NIPRO Corporation, Hamilton, SCHOTT AG, Gerresheimer AG, and Codan Medizinische Gerate GmbH & Co KG.

Syringes Market Taxonomy

On the basis of usability, the global syringes market is segmented into:

Sterilizable / Reusable Syringes

Disposable Syringes

On the basis of type, the global syringes market is segmented into:

General Syringes

Specialized Syringes

On the basis of material, the global syringes market is segmented into:

Glass Syringes

Plastic Syringes

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/syringes-market-917

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Venipuncture is a perforation on a vein as part of a medical practice, basically to draw a blood sample and or to inject a drug into the body. This is done by intravenous cannulation. The venipuncture blood collection is carried out with the help of needle and syringes. Venipuncture is the oldest invasive procedures, which is carried out for five basic reasons and they are to collect blood for investigative purposes, identify the levels of blood components, and administer medications, nutrition, or chemotherapy, to eliminate blood due high presence of iron or erythrocytes and to collect blood which might be useful later in transfusion purpose. This can be possibly done with the use of venipuncture needle and with the immense increase in the blood test and blood collection, there is a proportional increase in the venipuncture needle and syringe market.

Download The PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/176

Excessive blood withdrawn may lead to hematocrit in older patients

According to Van Roekel, CEO Nuno Valentine, said that there are about half of doctors do not have sufficient funds to support a phlebotomist, and some are located in an area where there are no staff sufficient members. Mr. Kapadia, a chief medical officer of Iggbo, explains that bloodwork justifies about 75% if the medical decision. According to Van Roekel, there are 1 billion blood sample are drawn in the United States every year and out of which 50,000 blood draws in Houston daily. There are many literature stating that the excessive blood drawing from an individual causes a big setback in elderly person. A cohort study report states that public hospitals and university hospitals drew more blood for each test than that is followed in children's hospitals.

Median Cubital Vein to dominate the venipuncture needle and syringes market globally

The global venipuncture needle and syringes market is segmented on the basis of vein type, end user, and geography. On the basis of vein type, the market is divided into Cephalic Vein, Median Cubital Vein, and Basilic Vein. On the basis of end user, the market is divided into Hospitals, Diagnostic Labs and Physicians’ Offices.

Advanced syringe and methods to collect the blood sample to overtake the conventional way of blood collection emphasizing the growth in venipuncture needle and syringes market

Regional segmentation of the market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America accounts for the largest share in venipuncture needle and syringes market, mainly due to presence of key players and their application of advanced medical technologies to develop in countries such as the North America and Africa. Increase in the diagnostic test for any disease needs blood sample which therefore is useful to obtain results. Therefore, the use of venipuncture needles and syringes are proportionally increasing. In Africa according to World Health Organization, it is almost 85% of all the chronic disease needs blood test.

Key players in the global venipuncture needle and syringes market are developing new devices, which collect the required amount of blood

Key players operating the venipuncture needle and venipuncture syringes market include Smiths Medical, Becton, Dickinson and Company, and B. Braun Medical. Key players in the market globally are constantly working towards introducing innovative products which firstly identify veins and collect blood sample. With companies actively focused on research and development, a new product which is virtually painless way to draw blood. This company is expected to launch its product in mid 2017 as the company has responded to its pending queries from FDA.

Browse For More Information :  https://www.coherentmarketinsights.com/ongoing-insight/venipuncture-needle-and-syringes-market-176

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Prefilled syringes are ready to use pharmaceutical products used to deliver parenteral medications. These are mainly used for treatment of chronic conditions that require long-term and self-administration of medication. Prefilled syringes are the ideal choice for single-dose drugs, offering easy-to-use fixed dosage options, thereby helping pharmaceutical companies control costs by minimizing drug overfill, minimize m icrobial contaGlobal Prefilled Syringes  Market 2018 Scope Overview and Regional Trends By 2026mination and reduce dosing errors. Prefilled syringes make injections easier and safer for both doctors and patients, with the patient always receives the right amount of dosage without complications.

Request For A Sample Copy Of This Research Report:https://www.coherentmarketinsights.com/insight/request-sample/162

The prefilled syringes market is expected to gain steady traction in the foreseeable future, with the success and growth of biologics, increased global vaccination, increased drug self-administration trend, technological advancements in the manufacture of PFS, and development of advanced PFS would further augment market growth. For instance, Safelia auto injector developed by Nemera in 2017 won the ‘Patient Centricity & Customization’ innovation award at Pharmapack. Safelia is an innovative auto injector for prefilled syringes, available in variable sizes, suitable for large volume and high viscosity delivery through thinner needles.

Market Dynamics

Minimum environment exposure, easy administration, better patient compliance and 100% bioavailability are the factors expected to drive the prefilled syringes market growth in the forecast period. According to the World Journal of Pharmacy and Pharmaceutical Sciences 2016, more than 3.5 billion prefilled syringes are produced and used annually by patients and healthcare providers for the treatment of broad spectrum of conditions. The technological innovations and developments of prefilled syringes are contributing to the market growth. For instance, Gerresheimer introduced metal-free Luer Lock Gx RTF Syringe in 2017, without tungsten to create perfect primary packaging material for the biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal. However, availability of alternative systems such as nanopatches, microneedles, connected delivery devices, limited shelf life and stability issues of the drugs are the factors restraining the market growth.

Market Taxonomy

This report segments the global prefilled syringes market on the basis of drug type, material and geography. On the basis of product type, the prefilled syringes market is categorized into biologics, vaccines, insulin and others. Biologics are further categorized into monoclonal antibodies, blood products and others. Vaccines are further categorized into conjugated vaccines, live attenuated vaccines, recombinant vaccines and others. On the basis of material, the prefilled syringes market is categorized into glass and plastic/polymer. For comprehensive understanding of market dynamics, the global prefilled syringes market is analyzed across key geographical regions namely North America, Latin America, Europe, Asia Pacific, Middle East and Africa. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key features of the study:

This report provides in-depth analysis of the prefilled syringes market and its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2017 as the base year.

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.

It profiles leading players in the global prefilled syringes market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans.

Key companies covered as a part of this study include Becton Dickinson & Co., Gerresheimer, Medtronic, Baxter International, SCHOTT AG, West Pharmaceuticals, Vetter International, Unilife Corporation, Stevanato Group and Terumo Corporation.

Click To Read More On Global Prefilled Syringes Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Prefilled syringes are ready to use pharmaceutical products used to deliver parenteral medications. These are mainly used for treatment of chronic conditions that require long-term and self-administration of medication. Prefilled syringes are the ideal choice for single-dose drugs, offering easy-to-use fixed dosage options, thereby helping pharmaceutical companies control costs by minimizing drug overfill, minimize microbial contamination and reduce dosing errors. Prefilled syringes make injections easier and safer for both doctors and patients, with the patient always receives the right amount of dosage without complications.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/162

The prefilled syringes market is expected to gain steady traction in the foreseeable future, with the success and growth of biologics, increased global vaccination, increased drug self-administration trend, technological advancements in the manufacture of PFS, and development of advanced PFS would further augment market growth. For instance, Safelia auto injector developed by Nemera in 2017 won the ‘Patient Centricity & Customization’ innovation award at Pharmapack. Safelia is an innovative auto injector for prefilled syringes, available in variable sizes, suitable for large volume and high viscosity delivery through thinner needles.

Market Dynamics

Minimum environment exposure, easy administration, better patient compliance and 100% bioavailability are the factors expected to drive the prefilled syringes market growth in the forecast period. According to the World Journal of Pharmacy and Pharmaceutical Sciences 2016, more than 3.5 billion prefilled syringes are produced and used annually by patients and healthcare providers for the treatment of broad spectrum of conditions. The technological innovations and developments of prefilled syringes are contributing to the market growth. For instance, Gerresheimer introduced metal-free Luer Lock Gx RTF Syringe in 2017, without tungsten to create perfect primary packaging material for the biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal. However, availability of alternative systems such as nanopatches, microneedles, connected delivery devices, limited shelf life and stability issues of the drugs are the factors restraining the market growth.

Market Taxonomy

This report segments the global prefilled syringes market on the basis of drug type, material and geography. On the basis of product type, the prefilled syringes market is categorized into biologics, vaccines, insulin and others. Biologics are further categorized into monoclonal antibodies, blood products and others. Vaccines are further categorized into conjugated vaccines, live attenuated vaccines, recombinant vaccines and others. On the basis of material, the prefilled syringes market is categorized into glass and plastic/polymer. For comprehensive understanding of market dynamics, the global prefilled syringes market is analyzed across key geographical regions namely North America, Latin America, Europe, Asia Pacific, Middle East and Africa. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key features of the study:

This report provides in-depth analysis of the prefilled syringes market and its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2017 as the base year.

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.

It profiles leading players in the global prefilled syringes market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans.

Key companies covered as a part of this study include Becton Dickinson & Co., Gerresheimer, Medtronic, Baxter International, SCHOTT AG, West Pharmaceuticals, Vetter International, Unilife Corporation, Stevanato Group and Terumo Corporation.

Click To Read More On Global Prefilled Syringes Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Prefilled syringes are ready to use pharmaceutical products used to deliver parenteral medications. These are mainly used for treatment of chronic conditions that require long-term and self-administration of medication. Prefilled syringes are the ideal choice for single-dose drugs, offering easy-to-use fixed dosage options, thereby helping pharmaceutical companies control costs by minimizing drug overfill, minimize microbial contamination and reduce dosing errors. Prefilled syringes make injections easier and safer for both doctors and patients, with the patient always receives the right amount of dosage without complications.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/162

The prefilled syringes market is expected to gain steady traction in the foreseeable future, with the success and growth of biologics, increased global vaccination, increased drug self-administration trend, technological advancements in the manufacture of PFS, and development of advanced PFS would further augment market growth. For instance, Safelia auto injector developed by Nemera in 2017 won the ‘Patient Centricity & Customization’ innovation award at Pharmapack. Safelia is an innovative auto injector for prefilled syringes, available in variable sizes, suitable for large volume and high viscosity delivery through thinner needles.

Market Dynamics

Minimum environment exposure, easy administration, better patient compliance and 100% bioavailability are the factors expected to drive the prefilled syringes market growth in the forecast period. According to the World Journal of Pharmacy and Pharmaceutical Sciences 2016, more than 3.5 billion prefilled syringes are produced and used annually by patients and healthcare providers for the treatment of broad spectrum of conditions. The technological innovations and developments of prefilled syringes are contributing to the market growth. For instance, Gerresheimer introduced metal-free Luer Lock Gx RTF Syringe in 2017, without tungsten to create perfect primary packaging material for the biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal. However, availability of alternative systems such as nanopatches, microneedles, connected delivery devices, limited shelf life and stability issues of the drugs are the factors restraining the market growth.

Market Taxonomy

This report segments the global prefilled syringes market on the basis of drug type, material and geography. On the basis of product type, the prefilled syringes market is categorized into biologics, vaccines, insulin and others. Biologics are further categorized into monoclonal antibodies, blood products and others. Vaccines are further categorized into conjugated vaccines, live attenuated vaccines, recombinant vaccines and others. On the basis of material, the prefilled syringes market is categorized into glass and plastic/polymer. For comprehensive understanding of market dynamics, the global prefilled syringes market is analyzed across key geographical regions namely North America, Latin America, Europe, Asia Pacific, Middle East and Africa. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key features of the study:

This report provides in-depth analysis of the prefilled syringes market and its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2017 as the base year.

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.

It profiles leading players in the global prefilled syringes market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans.

Key companies covered as a part of this study include Becton Dickinson & Co., Gerresheimer, Medtronic, Baxter International, SCHOTT AG, West Pharmaceuticals, Vetter International, Unilife Corporation, Stevanato Group and Terumo Corporation. 

Click To Read More On Global Prefilled Syringes Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.